Join the club for FREE to access the whole archive and other member benefits.


Concr predicts cancer treatment outcomes

Concr, a London-based techbio company, applies astrophysics methods to predict cancer treatment outcomes. Their platform, FarrSight®, enables accurate tumor modeling and clinical trial simulations, revolutionizing therapy prediction without relying on extensive data. With investors like University of Cambridge Enterprise and Oncology Ventures, Concr aims to reshape cancer treatment paradigms globally.

Visit website:


Concr News

AI can predict how early breast cancer patients might respond to their treatments

Durham University - 09-Feb-2024

This could lead to more personalised treatment plans and better outcomes